Medication info

Ducaine Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
white cream
Packaging
500 grams/bottle
Approval status
Active

MFDS item code 202002670 · Notified 2020.04.16

Summary

Main use
Pain relief during treatment of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. The area should usually remain covered for 1-3 hours, and the effect persists for at least 1 hour after the dressing is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply about 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5 -2g/10㎠ of this medicine for 1 hour. 3) For major superficial surgery (e.g., split-skin grafting), apply 1.5-2g/10㎠ of this medicine for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomata, apply about 10g of this medicine to the treatment area for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube once and discard any remaining cream after each application. Apply 1-2g/10㎠ for at least 30 minutes, and do not exceed 10g at each treatment. For leg ulcers with tissue that is difficult to debride, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed with up to 15 applications over 1-2 months.
Children's dosage
○ Infants aged 3 months–12 months: Total amount 2g; do not exceed an application area of 16㎠.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Pain relief during treatment of the skin, genital mucosa, and leg ulcers

  • Surface anesthesia of the skin
  • surface anesthesia of the genital mucosa
  • surface anesthesia for leg ulcers
View approved original text

This medication is used to anesthetize the surface of the skin during the insertion of a needle or superficial surgical procedures. It is also utilized for surface anesthesia of the genital mucosa, reducing pain during procedures such as the removal of condylomas. Surface anesthesia is performed before cleaning or superficial surgery on leg ulcers to alleviate discomfort. It is effective for surface anesthesia in various areas and helps to reduce pain for patients before procedures.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. The area should usually remain covered for 1-3 hours, and the effect persists for at least 1 hour after the dressing is removed. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply about 2g of this medicine for a minimum of 1 hour and a maximum of 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5 -2g/10㎠ of this medicine for 1 hour. 3) For major superficial surgery (e.g., split-skin grafting), apply 1.5-2g/10㎠ of this medicine for a minimum of 2 hours and a maximum of 5 hours. 2. Genital mucosa: For removal of condylomata, apply about 10g of this medicine to the treatment area for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use each opened tube once and discard any remaining cream after each application. Apply 1-2g/10㎠ for at least 30 minutes, and do not exceed 10g at each treatment. For leg ulcers with tissue that is difficult to debride, the application time may be extended to 60 minutes; cleanse the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed with up to 15 applications over 1-2 months.

Children's dosage

○ Infants aged 3 months–12 months: Total amount 2g; do not exceed an application area of 16㎠.

Precautions

This medication is used as a local anesthetic and may cause a rare blood disorder known as methemoglobinemia. This condition reduces the blood's capacity to transport oxygen, leading to symptoms such as a bluish discoloration of the skin. Special caution is needed for patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, those with heart or lung damage, infants under 6 months, and those using oxidizing agents, as they are more sensitive to this symptom. After using this medication, monitoring for symptoms and signs of methemoglobinemia is essential. This medication should not be used in patients with hypersensitivity to the components or amide-type local anesthetics, in areas with wounds or dermatitis, in infants under 3 months, and in infants under 12 months receiving medications that can cause methemoglobinemia, as well as in preterm infants born before 37 weeks of gestation. It should be used cautiously in patients with anemia, methemoglobinemia, or those taking related medications, frail or elderly patients, patients with acute conditions, severe liver disease, and those with allergies to propylene glycol, a component of this medication. Local reactions such as pallor, redness, swelling, itching, and burning may occur, and rare allergic reactions such as hives, angioedema, and bronchospasm may also occur. This medication should not be applied to the eyes or ears as it may cause irritation or toxicity. In case of overdose, symptoms may appear in the central nervous system or cardiac issues, and immediate treatment is necessary, with careful observation for several hours post-treatment. Caution is advised when using this medication during pregnancy or breastfeeding as it may pass through the placenta and be excreted in breast milk. Its safety and efficacy in children, especially infants under 3 months, have not been adequately confirmed, thus usage in mucosal areas is not recommended. Additionally, the risk of methemoglobinemia may increase when used with certain other medications, so be cautious with drug combinations. Lastly, long-term high-dose use of this medication may increase the risk of cancer, so it is essential to strictly adhere to the recommended dosage and duration of use.

Side effects

  • Localized pallor
  • redness
  • swelling
  • itching
  • initial burning sensation
  • urticaria
  • angioedema
  • bronchospasm
  • shock
  • methemoglobinemia
Show 3 more
  • purpura
  • petechiae
  • corneal irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

white cream

Package unit

500 grams/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.